Business Wire | Nov 4, 2021 04:07PM EDT

Quantum-Si to Participate in the 2021 Canaccord Genuity Virtual MedTech, Diagnostics and Digital Health & Services Forum

Nov. 04, 2021

GUILFORD, Conn.--(BUSINESS WIRE)--Nov. 04, 2021--Quantum-Si Incorporated (Nasdaq: QSI), a life sciences tools company commercializing a unique protein sequencing platform, today announced that it will participate in the 2021 Canaccord Genuity Virtual MedTech, Diagnostics and Digital Health & Services Forum. John Stark, Chief Executive Officer, and Claudia Drayton, Chief Financial Officer, will participate in a virtual fireside chat on Thursday, November 18, 2021 at 2:30 p.m. ET.

A webcast of the event will be available on the Investors section of Quantum-Si's website under Events & Presentations. A replay will be available on the Company's website after the event.

About Quantum-Si

Founded by Dr. Jonathan Rothberg in 2013, Quantum-Si is focused on revolutionizing the growing field of proteomics. The Company's suite of technologies is powered by a first-of-its-kind semiconductor chip designed to enable single-molecule next-generation protein sequencing, and digitize proteomic research in order to advance drug discovery and diagnostics beyond what has been possible with DNA sequencing.

View source version on businesswire.com: https://www.businesswire.com/news/home/20211104006292/en/

CONTACT: Investor Contacts Juan Avendano VP of Investor Relations (413) 537-8735 javendano@quantum-si.com Mike Cavanaugh ICR Westwicke (617) 877-9641 ir@quantum-si.com Media Contact Cammy Duong ICR Westwicke (203) 682-8380 QSI-PR@westwicke.com